# Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/elacestrant-oral-selective-estrogen-receptor-degrader-versus-standard-endocrine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | François‐Clément Bidard,Virginia Kaklamani,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frédéric Forget,Marie‐Ange Mouret‐Reynier,Joohyuk Sohn,Donatienne Taylor,Kathleen Harnden,Hung T. Khong,Judit Kocsis,Florence Dalenc,Patrick M. Dillon,Sunil Babu,Simon Waters,Ines Deleu,José Á. García-Sáenz,Emilio Bria,Marina Elena Cazzaniga,Janice Lu,Philippe Aftimos,Javier Cortés,Shubin Liu,Giulia Tonini,Dirk Laurent,Nassir Habboubi,Maureen G. Conlan,Aditya Bardia |
| Citations | 719 |
| DOI | 10.1200/jco.22.00338 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00338?role=tab |
| OpenAlex ID | https://openalex.org/W4280490473 |
| PMID | 35584336 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Alberto J. Montero](https://scholariq.org/researchers/alberto-j-montero/)
- [Philippe Aftimos](https://scholariq.org/researchers/philippe-aftimos/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.